[1]
Ravasio, R. and Ripoli, S. 2023. Cost-minimization analysis of HYQVIA® in the treatment of primary immunodeficiency disease (PID) and secondary immunodeficiency disease (SID) in Italy. AboutOpen. 10, 1 (May 2023), 69–77. DOI:https://doi.org/10.33393/ao.2023.2584.